Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry

BACKGROUND: Where health economic studies are frequently performed using modelling, with input from randomized controlled trials and best guesses, we used real-life data to analyse the cost-effectiveness and cost-utility of a treatment strategy aiming to the target of remission compared to usual car...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeer, Marloes, Kievit, Wietske, Kuper, Hillechiena H, Braakman-Jansen, Louise MA, Bernelot Moens, Hein J, Zijlstra, Theo R, den Broeder, Alfons A, van Riel, Piet LCM, Fransen, Jaap, van de Laar, Mart AFJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884120/
https://www.ncbi.nlm.nih.gov/pubmed/24330489
http://dx.doi.org/10.1186/1471-2474-14-350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884120/
https://www.ncbi.nlm.nih.gov/pubmed/24330489
http://dx.doi.org/10.1186/1471-2474-14-350

Ejemplares similares